John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNCL
1126
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $2.54M | 0.01% |
177,998
+20,352
| +13% | +$315K |
|
|
SDRL
1127
DELISTED
Seadrill Limited Common Stock
SDRL
| $2.54M | 0.01% |
262,277
+69,145
| +36% | +$1.2M |
|
1128
PUT
PepsiCo
PEP
$197B
| $2.54M | 0.01% |
23,000
-94,400
| -80% | -$10.6M |
|
|
XOG
1129
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $2.54M | 0.01% |
+592,091
| New | +$4.41M |
|
|
INN
1130
Summit Hotel Properties
INN
$662M
| $2.53M | 0.01% |
260,418
+236,975
| +1,011% | +$2.69M |
|
1131
Puma Biotechnology
PBYI
$471M
| $2.53M | 0.01% |
+124,412
| New | +$3.73M |
|
1132
CEVA Inc
CEVA
$751M
| $2.53M | 0.01% |
114,554
-22,841
| -17% | -$571K |
|
1133
Alamos Gold
AGI
$16B
| $2.53M | 0.01% |
+702,465
| New | +$2.75M |
|
|
TYPE
1134
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $2.53M | 0.01% |
162,928
+14,344
| +10% | +$255K |
|
|
SCS
1135
DELISTED
Steelcase
SCS
| $2.53M | 0.01% |
170,460
+138,424
| +432% | +$2.25M |
|
1136
Perrigo
PRGO
$1.98B
| $2.53M | 0.01% |
+65,217
| New | +$4.14M |
|
|
EA
1137
PUT
DELISTED
Electronic Arts
EA
| $2.52M | 0.01% |
32,000
+12,900
| +68% | +$1.18M |
|
1138
Hilton Grand Vacations
HGV
$3.53B
| $2.52M | 0.01% |
95,445
-211,044
| -69% | -$6.12M |
|
1139
PUT
Walmart Inc
WMT
$847B
| $2.52M | 0.01% |
81,000
-12,000
| -13% | -$385K |
|
|
ACOR
1140
DELISTED
Acorda Therapeutics
ACOR
| $2.51M | 0.01% |
+1,342
| New | +$2.92M |
|
1141
CALL
Visa
V
$714B
| $2.51M | 0.01% |
19,000
-22,000
| -54% | -$3.04M |
|
1142
Travelers Companies
TRV
$77.3B
| $2.5M | 0.01% |
20,835
-676,004
| -97% | -$84.6M |
|
1143
Albany International
AIN
$1.66B
| $2.49M | 0.01% |
39,943
-8,388
| -17% | -$585K |
|
1144
iShares Mortgage Real Estate ETF
REM
$544M
| $2.49M | 0.01% |
62,400
+3,400
| +6% | +$144K |
|
1145
Vulcan Materials
VMC
$35.8B
| $2.49M | 0.01% |
+25,224
| New | +$2.56M |
|
|
1146
PUT
SLB Ltd
SLB
$80.1B
| $2.49M | 0.01% |
69,000
-117,500
| -63% | -$5.8M |
|
|
CTRL
1147
DELISTED
Control4 Corporation
CTRL
| $2.47M | 0.01% |
140,444
+87,626
| +166% | +$2.07M |
|
1148
Johnson Controls International
JCI
$86.6B
| $2.46M | 0.01% |
+82,939
| New | +$2.74M |
|
|
GOOD
1149
Gladstone Commercial Corp
GOOD
$638M
| $2.46M | 0.01% |
137,135
+41,781
| +44% | +$783K |
|
1150
Hubbell
HUBB
$24.7B
| $2.46M | 0.01% |
+24,733
| New | +$2.71M |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.